STOCK TITAN

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

FocalTherics (Nasdaq: FOCL) announced that CEO Ryan Rhodes will present at the H.C.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

FocalTherics (Nasdaq: FOCL) announced that CEO Ryan Rhodes will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, held September 14-16, 2026. The company’s presentation is scheduled for Tuesday, September 15, 2026, from 10:30-11:00 AM ET and will be webcast live.

Rhodes and CFO Ken Mobeck will also host 1x1 investor meetings on September 15-16, 2026. A live and archived webcast of the presentation will be available via the provided conference link and through the Investors section of FocalTherics’ website.

Loading...
Loading translation...
Argus Sep 1 session
+0.94% close to close Open Argus
Details

News Market Reaction – FOCL

On Sep 1, the day this news came out, FOCL closed 0.94% above the previous close.

Data tracked by StockTitan Argus for the Sep 1 session.

Key Figures

Conference edition: 28th annual Conference dates: September 14-16, 2026 Presentation date: September 15, 2026 +2 more
Conference edition
28th annual
H.C. Wainwright Global Investment Conference
Conference dates
September 14-16, 2026
New York, New York
Presentation date
September 15, 2026
Scheduled conference presentation
Investor meetings
1x1
Tuesday and Wednesday, September 15-16, 2026
Presentation time
10:30-11:00 AM ET
Tuesday, September 15, 2026

Historical Context

5 past events · Latest: Aug 13
5 events
  1. Aug 13

    Q2 earnings report

    24h Move
    +2.6%

    Revenue growth, improved gross margin, reiterated 2026 guidance, and expanded system installations

  2. Aug 11

    Public offering pricing

    24h Move
    -21.0%

    Company priced an underwritten ADS offering targeting approximately $40.0 million gross proceeds

  3. Aug 11

    Preliminary Q2 results

    24h Move
    -21.0%

    Preliminary results accompanied segment reclassification and a reported strategic operating shift

  4. Aug 11

    Proposed public offering

    24h Move
    -21.0%

    Company proposed an underwritten ADS offering for operating and general corporate purposes

  5. Jul 30

    Q2 earnings scheduling

    24h Move
    -0.3%

    Company scheduled release of second-quarter financial results and conference call

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

robotic focal therapy, 1x1 investor meetings
2 terms
robotic focal therapy medical
"a global leader in robotic focal therapy"
A minimally invasive cancer treatment that uses imaging and computer-guided robotic systems to target and destroy only the diseased portion of an organ, such as a section of the prostate, while sparing healthy tissue. It matters to investors because it represents a technology-driven medical procedure with potential commercial implications for device makers, hospitals, and payers: adoption, regulatory clearance, and reimbursement can affect revenue and market growth for firms involved in the equipment and supporting services.
1x1 investor meetings financial
"will also host 1x1 investor meetings at the conference"
1x1 investor meetings are private discussions between a company's management and individual investors, typically lasting around an hour. These meetings allow investors to ask questions, gain a deeper understanding of the company's strategy and performance, and build a direct relationship with leadership. They matter to investors because they provide valuable insights that can influence investment decisions and foster greater confidence in the company's prospects.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026


FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026

AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 in New York, New York. Rhodes, together with Ken Mobeck, Chief Financial Officer, will also host 1x1 investor meetings at the conference on Tuesday and Wednesday, September 15-16, 2026.


Date: Tuesday, September 15, 2026

Time: 10:30-11:00 AM ET

Format: Presentation

Webcast: https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.

About FocalTherics  
A recognized global leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.


Investor Contact

Louisa Smith
Gilmartin Group
Investor.relations@focalone.com



 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will FocalTherics (NASDAQ: FOCL) present at the H.C. Wainwright 28th Annual Global Investment Conference?

FocalTherics will present on Tuesday, September 15, 2026, from 10:30-11:00 AM ET. According to FocalTherics, this presentation is part of the H.C. Wainwright 28th Annual Global Investment Conference held September 14-16, 2026, in New York.

How can investors access the FocalTherics (FOCL) webcast from the H.C. Wainwright 2026 conference?

Investors can access the live and archived webcast via https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59. According to FocalTherics, the webcast will also be available in the Investors section of the company’s website after the event.

Who will represent FocalTherics (FOCL) at the H.C. Wainwright 28th Annual Global Investment Conference in September 2026?

FocalTherics will be represented by CEO Ryan Rhodes and CFO Ken Mobeck. According to FocalTherics, Rhodes will give the main presentation, and both executives will host 1x1 investor meetings during the conference.

Will FocalTherics (FOCL) hold 1x1 investor meetings at the H.C. Wainwright 2026 conference?

Yes, FocalTherics will host 1x1 investor meetings on September 15-16, 2026. According to FocalTherics, CEO Ryan Rhodes and CFO Ken Mobeck will meet individually with investors alongside the formal conference presentation.

Where is the H.C. Wainwright 28th Annual Global Investment Conference featuring FocalTherics (FOCL) being held?

The conference is being held in New York, New York, from September 14-16, 2026. According to FocalTherics, the company’s scheduled presentation and 1x1 investor meetings will take place during this multi-day event in New York.

Keep reading